EV Hotel Corp. entered into non-binding letter of intent to acquire Plandaf Biotechnology, Inc. (OTCPK:PLPL) in a reverse merger transaction on October 6, 2022. EV Hotel Corp.

agreed to acquire Plandaf Biotechnology, Inc. (OTCPK:PLPL) in a reverse merger transaction on November 8, 2022. Upon closing of the transaction will close and the Company will acquire all of the authorized stock and assets in EV HotelÖ in exchange for common stock and all of the Company's Series "A" Preferred stock, resulting in a change of control. Conditions to the closing of the asset acquisition include both parties completing independent financial audits, and the Company completing corporate actions with the Secretary of State of Nevada and FINRA that will change the name and trading symbol of the Company, along with a reverse split of the Company's common stock, which management plans at 100:1. The merger will return value to our shareholders.

The Company will diligently complete its conditions to closing and expect the independent audit of the Company will be completed this week.